Latest Clinicians’ U.S. Survey Identifies Point of Care Testing (POCT) as a Way to…
WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced findings from its second annual…